Einträge von Baumert, Brigitta G. auf dem Publikationsserver

van den Bent, Martin J., Tesileanu, C. Mircea S. , Wick, Wolfgang, Sanson, Marc, Brandes, Alba Ariela, Clement, Paul M., Erridge, Sarah, Vogelbaum, Michael A., Nowak, Anna K. , Baurain, Jean Français, Mason, Warren P., Wheeler, Helen, Chinot, Olivier L., Gill, Sanjeev, Griffin, Matthew, Rogers, Leland, Taal, Walter , Rudà, Roberta, Weller, Michael, McBain, Catherine, Reijneveld, Jaap, Enting, Roelien H., Caparrotti, Francesca, Lesimple, Thierry, Clenton, Susan, Gijtenbeek, Anja, Lim, Elizabeth, Herrlinger, Ulrich, Hau, Peter, Dhermain, Frederic, de Heer, Iris, Aldape, Kenneth, Jenkins, Robert B., Dubbink, Hendrikus Jan, Kros, Johan M., Wesseling, Pieter, Nuyens, Sarah, Golfinopoulos, Vassilis, Gorlia, Thierry, French, Pim und Baumert, Brigitta G. (2021) Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study. The Lancet Oncology 22 (6), S. 813-823. Volltext nicht vorhanden.

Reijneveld, Jaap C., Taphoorn, Martin J. B., Coens, Corneel, Bromberg, Jacoline E. C., Mason, Warren P., Hoang-Xuan, Khê, Ryan, Gail, Hassel, Mohamed Ben, Enting, Roelien H., Brandes, Alba A., Wick, Antje, Chinot, Olivier, Reni, Michele, Kantor, Guy, Thiessen, Brian, Klein, Martin, Verger, Eugenie, Borchers, Christian, Hau, Peter, Back, Michael, Smits, Anja, Golfinopoulos, Vassilis, Gorlia, Thierry, Bottomley, Andrew, Stupp, Roger und Baumert, Brigitta G. (2016) Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. The Lancet Oncology 17 (11), S. 1533-1542. Volltext nicht vorhanden.